Dashboard
Manage Tickers

BCABBioAtla, Inc.


$ 3.10 $ 0.10 (3.33 %)    

Thursday, 16-May-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
$ 2.95
$ 0.00 x 0
$ 0.00 x 0
$ 2.95 - $ 3.32
$ 1.24 - $ 4.02
668,694
na
149.07M
$ 2.59
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-bioatla-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on BioA...
05/15/2024 15:19:29

HC Wainwright & Co. analyst Arthur He reiterates BioAtla (NASDAQ:BCAB) with a Buy and maintains $7 price target.

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/14/2024 20:31:13

bioatla-q1-2024-gaap-eps-048-beats-054-estimate
BioAtla Q1 2024 GAAP EPS $(0.48) Beats $(0...
05/14/2024 20:23:31

BioAtla (NASDAQ:BCAB) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.54) by 11...

bioatla-announces-fda-clearance-of-investigational-new-drug-application-for-ba3361
BioAtla Announces FDA Clearance Of Investi...
05/06/2024 12:07:44

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 16:31:17

jmp-securities-reiterates-market-outperform-on-bioatla-maintains-12-price-target
JMP Securities Reiterates Market Outperfor...
03/28/2024 14:34:55

JMP Securities analyst Reni Benjamin reiterates BioAtla (NASDAQ:BCAB) with a Market Outperform and maintains $12 price target.

hc-wainwright--co-maintains-buy-on-bioatla-lowers-price-target-to-7
HC Wainwright & Co. Maintains Buy on BioAt...
03/27/2024 10:26:29

HC Wainwright & Co. analyst Arthur He maintains BioAtla (NASDAQ:BCAB) with a Buy and lowers the price target from $10 to...

bioatla-q4-eps-056-beats-079-estimate
BioAtla Q4 EPS $(0.56) Beats $(0.79) Estimate
03/26/2024 21:35:40

BioAtla (NASDAQ:BCAB) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.79) by 29...

bioatla-q4-earnings-insights
BioAtla: Q4 Earnings Insights
03/26/2024 21:35:13

earnings-scheduled-for-march-26-2024
Earnings Scheduled For March 26, 2024
03/26/2024 08:47:27

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...

preview-bioatlas-earnings
Preview: BioAtla's Earnings
03/25/2024 16:00:39

around-2m-bet-on-this-healthcare-stock-check-out-these-4-penny-stocks-insiders-are-aggressively-buying
Around $2M Bet On This Healthcare Stock? C...
12/20/2023 13:31:54

The Dow Jones index closed higher by around 250 points on Tuesday. When insiders purchase or sell shares, it indicates their co...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
12/18/2023 21:31:50

bioatla-hosting-virtual-rd-day-to-highlight-ba3071-cab-ctla-4-phase-1-data-in-multiple-solid-tumor-types
BioAtla Hosting Virtual R&D Day To Highlig...
12/13/2023 13:23:30

Multiple confirmed responses and durable disease control observed Emerging differentiated safety profile enables further explor...

jmp-securities-reiterates-market-outperform-on-bioatla-maintains-12-price-target
JMP Securities Reiterates Market Outperfor...
12/05/2023 14:17:31

JMP Securities analyst Reni Benjamin reiterates BioAtla (NASDAQ:BCAB) with a Market Outperform and maintains $12 price target.

bioatla-presented-phase-2-clinical-trial-data-at-the-iaslc-2023-north-america-conference-on-lung-cancer-and-virtual-kol-event
BioAtla Presented Phase 2 Clinical Trial D...
12/05/2023 13:07:36

Results from the Phase 2 BA3011 clinical non-small cell lung cancer (NSCLC) study demonstrated promising clinical benefits in h...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
12/04/2023 17:31:02

hc-wainwright--co-maintains-buy-on-bioatla-lowers-price-target-to-10
HC Wainwright & Co. Maintains Buy on BioAt...
11/08/2023 13:11:40

HC Wainwright & Co. analyst Arthur He maintains BioAtla (NASDAQ:BCAB) with a Buy and lowers the price target from $17 to...

bioatla-q3-2023-cash-cash-equivalents-1413m
BioAtla Q3 2023 Cash, Cash Equivalents $14...
11/07/2023 21:04:41

bioatla-sees-h2-2025-cash-balance-1413m
BioAtla Sees H2 2025 Cash Balance $141.3M
11/07/2023 21:04:09

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION